Jennifer Chien
Corporate Officer/Principal en RHYTHM PHARMACEUTICALS, INC. .
Fortuna: 261 404 $ al 30/04/2024
Cargos activos de Jennifer Chien
Empresas | Cargo | Inicio | Fin |
---|---|---|---|
RHYTHM PHARMACEUTICALS, INC. | Corporate Officer/Principal | 09/11/2020 | - |
Historial de carrera de Jennifer Chien
Antiguos cargos conocidos de Jennifer Chien.
Empresas | Cargo | Inicio | Fin |
---|---|---|---|
KRYSTAL BIOTECH, INC. | Corporate Officer/Principal | 20/01/2020 | 16/10/2020 |
Genzyme Therapeutics Ltd.
Genzyme Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Genzyme Therapeutics Ltd. develops transformative therapies for patients affected by rare and debilitating diseases. Its treatment areas include thyroid cancer, sclerosis, Fabry disease and Pompe. The company was founded on November 5, 2001 and is headquartered in Oxford, the United Kingdom. | Corporate Officer/Principal | 01/11/2014 | 01/01/2020 |
Formación de Jennifer Chien.
Massachusetts Institute of Technology | Undergraduate Degree |
Harvard University | Graduate Degree |
Estadísticas
Internacional
Estados Unidos | 5 |
Reino Unido | 2 |
Operativa
Corporate Officer/Principal | 3 |
Undergraduate Degree | 1 |
Graduate Degree | 1 |
Sectorial
Health Technology | 4 |
Finance | 2 |
Consumer Services | 2 |
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Empresas relacionadas
Empresas cotizadas | 2 |
---|---|
KRYSTAL BIOTECH, INC. | Health Technology |
RHYTHM PHARMACEUTICALS, INC. | Health Technology |
Empresas privadas | 1 |
---|---|
Genzyme Therapeutics Ltd.
Genzyme Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Genzyme Therapeutics Ltd. develops transformative therapies for patients affected by rare and debilitating diseases. Its treatment areas include thyroid cancer, sclerosis, Fabry disease and Pompe. The company was founded on November 5, 2001 and is headquartered in Oxford, the United Kingdom. | Health Technology |
- Bolsa de valores
- Insiders
- Jennifer Chien
- Experiencia